GoodRx could seek up to $969M in IPO
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
GoodRx priced its long-awaited IPO between $24 and $28 per share. The company could raise up to $969 million in funding.
GoodRx, a startup that makes tools for comparing the price of prescription drugs, is looking to go public, according to a report by Reuters. The company reportedly submitted paperwork to the Securities and Exchange Commission.
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.